Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [517]
News [1431]
Articles [66]
Editorials [2]
Conferences [72]
elearning [5]
Scientists discover why patients respond to a melanoma drug
Scientists discover why patients respond to a melanoma drug
Five studies reveal insights into cancers responding to checkpoint blockade
Five studies reveal insights into cancers responding to checkpoint blockade
Acid reflux medicines improve survival for patients with head and neck squamous cell carcinoma
Acid reflux medicines improve survival for patients with head and neck squamous cell carcinoma
The leading oncology channel goes for gold
The leading oncology channel goes for gold
Common antacid could lead to cheaper anti-cancer drugs
Common antacid could lead to cheaper anti-cancer drugs
Nivolumab can be effective for metastatic melanoma with wild type BRAF
Nivolumab can be effective for metastatic melanoma with wild type BRAF
Genes and sun behaviours during childhood may play large role in future melanoma risk
Genes and sun behaviours during childhood may play large role in future melanoma risk
Combination of PV-10 and checkpoint inhibitor boosts melanoma tumour regression
Combination of PV-10 and checkpoint inhibitor boosts melanoma tumour regression
MEK inhibitor cobimetinib added to BRAF inhibitor vemurafenib improves melanoma outcome
MEK inhibitor cobimetinib added to BRAF inhibitor vemurafenib improves melanoma outcome
MEK inhibitor trametinib added to the BRAF inhibitor dabrafenib improves melanoma outcome
MEK inhibitor trametinib added to the BRAF inhibitor dabrafenib improves melanoma outcome

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation